Documents published by MHRA (United Kingdom) on weight-management medicines, compounding and peptide products. Every link goes to the regulator's own page. Informational only.
Ask TinaTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Positive coverage and opinions: this section collects regulator announcements of approvals and authorizations.
UK first in Europe to authorise orforglipron for weight management and type 2 diabetesMHRA (United Kingdom) · 2026-08-10Semaglutide (Wegovy) approved to treat form of liver diseaseMHRA (United Kingdom) · 2026-07-03First GLP-1 tablet for weight loss approved in the UKMHRA (United Kingdom) · 2026-06-11Primary documents from the regulator for your own interpretation. No third-party commentary or opinion pieces.
MHRA updates guidance for GLP-1 prescribers and patientsMHRA (United Kingdom) · 2026-01-29GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal casesMHRA (United Kingdom) · 2026-01-29GLP-1 medicines for weight loss and diabetes: what you need to knowMHRA (United Kingdom) · 2025-06-04Ask Tina for links to further coverageTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Third-party links, listed for reference. Educational information only, not medical advice. Hypnotic Dose does not endorse any product.